Journal of Agricultural and Food Chemistry
Article
25.09, 25.19, 25.49, 25.60 [C(8)], 38.55, 38.57, 38.62, 38.64 [C(7)],
52.69 [C(4″, 4″′)], 54.00, 54.01 [C(4, 4′)], 71.99, 72.04, 72.30, 72.32
[C(5)], 94.91, 94.99 [C(2, 2′)], 95.95, 95.98 [C(2″, 2″′)].
Purification of 2-Benzyl-5-methyl-3-oxazoline (8; Figure 2D).
Elution was performed as follows: pentane (100 mL; fraction A),
pentane/diethyl ether (200 mL; 90:10 by vol; fraction B), pentane/
diethyl ether (150 mL; 90:10 by vol; fraction C), and pentane/diethyl
ether (50 mL; 90:10 by vol; fraction D). Fraction C containing 8 was
used for rechromatography as follows: pentane (100 mL; fraction A),
pentane/diethyl ether (250 mL; 90:10 by vol; fraction B), pentane/
diethyl ether (125 mL; 90:10 by vol; fraction C), pentane/diethyl
ether (100 mL; 80:20 by vol; fraction D), and pentane/diethyl ether
(100 mL; 80:20 by vol; fraction E). Isomer 8a was present in fraction
C, a mixture of compounds 8a and 8b was found in fraction D, and 8b
was isolated in fraction E. MS-EI, m/z (%) 84 (100), 91 (71), 57 (39),
92 (38), 65 (17), 77 (10), 41 (9), 104 (9), 131 (9), 103 (7), 78 (6),
130 (6), 39 (5), 44 (5), 105 (5), 40 (4), 42 (4), 43 (4), 54 (4), 55 (4),
56 (4), 85 (4), 173 (3), 175 (M+; 3), 174 ([M − H]+; 2); MS-CI, m/z
Purification of 2-sec-Butyl-5-methyl-3-oxazoline (4; Figure 2B).
Elution was performed as follows: pentane (100 mL; fraction A),
pentane/diethyl ether (150 mL; 95:5 by vol; fraction B), pentane/
diethyl ether (20 mL; 95:5 by vol; fraction C), pentane/diethyl ether
(50 mL; 95:5 by vol; fraction D), and pentane/diethyl ether (100 mL;
90:10 by vol; fraction E). Fraction B contained isomer 4a, and
fractions D and E contained isomer 4b. No further rechromatography
was needed. MS-EI, m/z (%) 84 (100), 56 (56), 57 (42), 112 (34), 85
(28), 41 (27), 70 (21), 68 (15), 86 (15), 55 (13), 83 (13), 126 (11),
42 (9), 43 (8), 97 (7), 39 (6), 58 (5), 140 (4), 140 ([M − H]+; 3),
1
141 (M+; tr); MS-CI, m/z (%) 142 ([M + H]+; 100), 143 (10); H
NMR (400 MHz; CD2Cl2) δ 0.89 [d, J = 6.8 Hz, 3H, H−C(10)], 0.95
[t, J = 7.4 Hz, 3H, H−C(9)], 1.16−1.29 [m, 1H, H−C(8a)], 1.29 [d, J
= 6.7 Hz, 3H, H−C(6)], 1.51−1.63 [m, 1H, H−C(8b)], 1.66−1.78
[m, 1H, H−C(7)], 4.79−4.87 [m, 1H, H−C(5)], 5.63−5.69 [m, 1H,
H−C(2)], 7.48 [d, J = 2.6 Hz, 1H, H−C(4)]; 13C NMR (100 MHz,
CD2Cl2) δ 11.88 [C(9)], 13.83 [C(10)], 18.60 [C(6)], 24.97 [C(8)],
40.74 [C(7)], 82.35 [C(5)], 109.80 [C(2)], 164.41 [C(4)].
1
(%) 176 ([M + H]+; 100), 177 (8); H NMR (400 MHz; CD2Cl2) δ
1.25 [d, J = 6.7 Hz, 3H, H−C(6)], 2.92 [dd, J = 13.8 Hz, 5.7 Hz, 1H,
H−C(7a)], 3.08 [dd, J = 13.8 Hz, 5.0 Hz, H−C(7b)], 4.67−4.70 [m,
1H, H−C(5)], 5.95−5.98 [m, 1H, H−C(2)], 7.22−7.33 [m, 5H, H−
C(9, 10, 11, 12, 13)], 7.40 [d, J = 2.4 Hz, 1H, H−C(4)]; 13C NMR
(100 MHz, CD2Cl2) δ 18.43 [C(6)], 42.11 [C(7)], 82.39 [C(5)],
106.58 [C(2)], 126.75 [C(11)], 128.46 [C(9, 13)], 130.40 [C(10,
12)], 106.58 [C(8)], 164.70 [C(4)].
Synthesis of 2-Isobutyl-3-oxazoline. 2-Isobutyl-3-oxazoline
(10; Figure 2E) was synthesized following the same approach
described above for 2-isobutyl-5-methyl-3-oxazoline (2) but using 2-
aminoethanol instead of (R)-1-amino-2-propanol in the reaction with
3-methylbutanal.
2-Isopropyl-5-methyl-3-oxazolidine (5; Figure 2C). MS-EI, m/z
(%) 84 (100), 86 (94), 41 (48), 70 (41), 58 (32), 55 (28), 56 (27), 42
(20), 59 (20), 43 (19), 85 (11), 39 (9), 45 (9), 57 (8), 68 (5), 83 (5),
40 (4), 54 (4), 69 (4), 82 (4), 87 (4), 114 (4), 128 ([M − H]+; 3),
1
129 (M+; tr); MS-CI, m/z (%) 130 ([M + H]+; 100), 131 (8); H
NMR (400 MHz; CDCl3) δ 0.96−1.01 [m, 12H, H−C(8, 8′, 9, 9′)],
1.19 [d, J = 6.2 Hz, 3H, H−C(6 or 6′)], 1.21 [d, J = 6.2 Hz, 3H, H−
C(6′ or 6)], 1.72−1.81 [m, 2H, H−C(7, 7′)], 2.54 [dd, J = 11.9, 7.7
Hz, 1H, H−C(4a′)], 2.68 [dd, J = 11.5, 5.0 Hz, 1H, H−C(4a)], 3.12
[dd, J = 11.5, 7.0 Hz, 1H, H−C(4b)], 3.35 [dd, J = 11.8, 6.1 Hz, 1H,
H−C(4b′)], 3.89−4.04 [m, 2H, H−C(5, 5′)], 4.15 [d, J = 5.8 Hz, 1H,
H−C(2)], 4.26 [d, J = 5.8 Hz, 1H, H−C(2′)]; 13C NMR (100 MHz,
CDCl3) δ 17.88 [C(8 or 8′ or 9 or 9′)], 17.94 [C(8 or 8′ or 9 or 9′)],
18.12 [C(8 or 8′ or 9 or 9′)], 18.17 [C(8 or 8′ or 9 or 9′)], 19.76 [C(6
or 6′)], 20.64 [C(6′ or 6)], 32.12 [C(7 or 7′)], 32.24 [C(7′ or 7)],
52.74 [C(4)], 54.03 [C(4′)], 72.22 [C(5 or 5′)], 72.46 [C(5′ or 5)],
96.05 [C(2′)], 97.04 [C(2)].
Analytical Data for 2-Isobutyl-3-oxazolidine and 2-Isobutyl-
3-oxazoline. 2-Isobutyl-3-oxazolidine (9; Figure 2E). MS-EI, m/z
(%) 72 (100), 56 (60), 42 (48), 44 (39), 87 (34), 41 (28), 45 (24),
114 (18), 39 (16), 43 (16), 55 (8), 84 (8), 98 (8), 40 (7), 54 (7), 57
(7), 88 (6), 69 (6), 89 (6), 53 (5), 68 (5), 96 (5), 128 ([M − H]+; 3),
1
129 (M+; tr); MS-CI, m/z (%) 130 ([M + H]+; 100), 131 (7); H
NMR (400 MHz; CDCl3) δ 0.91 [d, J = 6.7 Hz, 6H, H−C(8, 9)],
1.38−1.51 [m, 2H, H−C(6)], 1.69−1.78 [m, 1H, H−C(7)], 2.89−
2.96 [m, 1H, H−C(4a)], 3.13−3.29 [m, 1H, H−C(4b)], 3.59−3.63
[m, 2H, H−C(5)], 4.25−4.28 [m, 1H, H−C(2)]; 13C NMR (100
MHz, CDCl3) δ 22.61 [C(8 or 9)], 22.99 [C(9 or 8)], 25.45 [C(7)],
43.17 [C(6)], 46.22 [C(4)], 64.58 [C(5)], 91.11 [C(2)].
Purification of 2-Isopropyl-5-methyl-3-oxazoline (6; Figure 2C).
Elution was performed as follows: pentane (100 mL; fraction A),
pentane/diethyl ether (150 mL; 95:5 by vol; fraction B), pentane/
diethyl ether (100 mL; 90:10 by vol; fraction C), and pentane/diethyl
ether (50 mL; 90:10 by vol; fraction D). Fractions C and D contained
both isomers, but these could not be separated further. MS-EI, m/z
(%) 84 (100), 56 (36), 57 (35), 112 (26), 83 (20), 41 (15), 70 (12),
68 (11), 43 (9), 85 (9), 55 (5), 39 (4), 126 ([M − H]+; 3), 127 (M+;
Purification of 2-Isobutyl-3-oxazoline (10; Figure 2E). Stepwise
elution was performed as follows: pentane (100 mL; fraction A),
pentane/diethyl ether (50 mL; 95:5 by vol; fraction B), and pentane/
diethyl ether (100 mL; 95:5 by vol; fraction C). Due to the fact that
only one chiral center is present in the molecule, only one peak was
obtained in fraction C and, thus, no rechromatography was necessary.
MS-EI, m/z (%) 70 (100), 42 (21), 69 (19), 71 (19), 41 (18), 85 (14),
43 (12), 54 (12), 56 (9), 57 (8), 39 (8), 55 (4), 72 (4), 82 (4), 126
([M − H]+; 1), 127 (M+; tr); MS-CI, m/z (%) 128 ([M + H]+; 100),
129 (7); 1H NMR (400 MHz; CD2Cl2) δ 0.97 [d, J = 6.7 Hz, 6H, H−
C(8, 9)], 1.42−1.47 [m, 1H, H−C(6a)], 1.55−1.60 [m, 1H, H−
C(6b)], 1.82−1.90 [m, 1H, H−C(8)], 4.46−4.50 [m, 1H, H−C(5a)],
4.57−4.61 [m, 1H, H−C(5b)], 5.64−5.69 [m, 1H, H−C(2)], 7.55 [d,
J = 2.5 Hz, H−C(4)]; 13C NMR (100 MHz, CD2Cl2]) δ 22.73 [C(8)],
23.32 [C(9)], 25.29 [C(7)], 45.13 [C(6)], 75.16 [C(5)], 106.05
[C(2)], 160.31 [C(4)].
1
tr); MS-CI, m/z (%) 128 ([M + H]+; 100), 129 (8); H NMR (400
MHz; CDCl3) δ 0.93 [d, J = 6.8 Hz, 3H, H−C(8)], 0.96 [d, J = 6.8
Hz, 3H, H−C(9)], 1.29 [d, J = 6.7 Hz, 3H, H−C(6)], 1.91−1.99 [m,
1H, H−C(7)], 4.80−4.86 [m, 1H, H−C(5)], 5.56−5.59 [m, 1H, H−
C(2)], 7.48 [d, J = 2.5 Hz, 1H, H−C(4)]; 13C NMR (100 MHz,
CDCl3) δ 16.61 [C(8 or 9)], 17.26 [C(9 or 8)], 18.26 [C(6)], 33.52
[C(7)], 82.10 [C(5)], 110.25 [C(2)], 163.87 [C(4)].
2-Benzyl-5-methyl-3-oxazolidine (7; Figure 2D). MS-EI, m/z (%)
86 (100), 132 (54), 91 (37), 59 (22), 41 (17), 58 (17), 105 (16), 130
(12), 133 (12), 77 (10), 92 (10), 65 (9), 103 (9), 117 (9), 104 (8), 39
(6), 87 (6), 177 (M+; 6), 53 (4), 176 ([M − H]+; 2); MS-CI, m/z (%)
178 ([M + H]+; 100), 179 (12); 1H NMR (400 MHz; CD2Cl2) δ 0.89
[d, J = 6.1 Hz, 3H, H−C(6)], 0.96 [d, J = 6.1 Hz, 3H, H−C(6′)],
2.17−2.24 [m, 2H, H−C(4a, 4a′)], 2.69−2.76 [m, 2H, H−C(4b, 4b′)],
2.79−2.90 [m, 4H, H−C(7, 7′)], 3.59−3.69 [m, 2H, H−C(5, 5′)],
4.55 [t, J = 4.9 Hz, 1H, H−C(2)], 4.69 [t, J = 4.8 Hz, 1H, H−C(2′)],
7.05−7.09 [m, 2H, H−C(11, 11′)], 7.16−7.17 [m, 4H, H−C(10, 10′,
12, 12′)], 7.25−7.28 [m, 4H, H−C(9, 9′, 13, 13′)]; 13C NMR (100
MHz, CDCl3) δ 19.76 [C(6′)], 20.56 [C(6)], 40.45 [C(7′)], 40.91
[C(7)], 52.61 [C(4)], 53.94 [C(4′)], 72.27 [C(5′)], 72.33 [C(5)],
91.36 [C(2′)], 92.41 [C(2)], 126.40 [C(11)], 126.44 [C(11′)], 128.10
[C(10, 12)], 128.23 [C(10′, 12′)], 130.10 [C(9′, 13′)], 130.16 [C(9,
13)].
Synthesis of Isotopically Labeled Standards. [2H2]-3-Methyl-
butanal. 3-Methyl-3-buten-1-ol was deuterated using the Wilkinson
catalyst to obtain [3,4-2H2]-3-methylbutanol, which was subsequently
oxidized into [3,4-2H2]-3-methylbutanal by Dess−Martin period-
inane,16,17 following the approach reported previously for the synthesis
of [5,5,6,6-2H4]-hexanal.18
[2H2]-2-Methylbutanal. Starting from 2-methyl-3-buten-1-ol, the
target compound was synthesized following the two-step procedure
described for [2H2]-3-methylbutanal.
[2H2]-Methylpropanal. Starting from 2-methyl-2-propen-1-ol, the
target compound was synthesized following the two-step procedure
described for [2H2]-3-methylbutanal.
6315
dx.doi.org/10.1021/jf301489j | J. Agric. Food Chem. 2012, 60, 6312−6322